Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
November 12, 2021 at 07:01 am EST
Sio Gene Therapies Inc. reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported net loss was USD 21.24 million compared to USD 9.98 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to USD 0.21 a year ago.
For the six months, net loss was USD 33.11 million compared to USD 18.58 million a year ago. Basic loss per share from continuing operations was USD 0.45 compared to USD 0.41 a year ago.